Delivery Order SPE2DB22D3011-SPE2DB24FP9PT
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,250.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,250.40 award is for the supply of 4,563,898,453 units of the medication Contrave ER 8-90 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through...
- This $7,337.45 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication, with a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,028.78 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564244773 CONTRAVE ER 8-90 MG TABLET 120S. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,637.26 award is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $19,447.34 order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a specialty pharmaceutical product, with a performance period through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,191.55, is for the delivery of 4,564,261,053 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the holder of a $999,999,999.00 indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,291.90 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit AmerisourceBergen Corporation. The order is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S and has an ultimate completion date of April 15, 2024. This delivery order is under AmerisourceBergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with DLA to provide pharmaceutical products and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4563943282 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $4,583.75 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical that serves as the primary contract...
- This is a $23,018.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has an ultimate completion date of July 10, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9PTDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $4,509.06 order is for the supply of 120 tablets of the branded prescription medication CONTRAVE ER 8-90 MG. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. This IDC does not have a set-aside designation.
Generated 5/31/24, 10:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 3/1/24 |